Differences in providers' beliefs about benefits and risks of hormone replacement therapy in managed care

Journal of Women's Health

Volumn 7, Issue 7, 1998, Pages 879-884

  Exline, Joan L ^a   Siegler, Ilene C ^b   Bastian, Lori A ^c,d  

^a UNIVERSITY OF SOUTHERN MISSISSIPPI   (United States)

^b Dept of Psychiat and Behav Sci ^*  (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE;

ADULT; ALZHEIMER DISEASE; ARTICLE; BREAST CANCER; FEMALE; FEMALE PHYSICIAN; GENDER; GENERAL PRACTITIONER; GYNECOLOGY; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; HEART INFARCTION PREVENTION; HORMONE SUBSTITUTION; HUMAN; MALE; MANAGED CARE ORGANIZATION; NORMAL HUMAN; OSTEOPOROSIS; PHYSICIAN ASSISTANT; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM; UNITED STATES;

EID: 0031708650     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1998.7.879     Document Type: Article

References (24)

1. U.S. Department of Health and Human Services. Healthy people 2000: A national health promotion and disease prevention objectives. Boston: Jones and Bartlett, 1992.
2. Col NF, Eckman MH, Karas RH, et al. Patient-specific decisions about HRT in postmenopausal women. JAMA 1997;277:1140.
3. Bastian LA, Couchman GM, Rimer BK, et al. Hormonal replacement therapy and informed decision making about cancer risks. In: Bennett CL, ed. Cancer policy. Norwell MA: Kluwer Academic Publishers, 1998.
4. Ettinger B, Friedman GD, Bush T, Quesenberry CP. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996; 87:6.
5. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336:1769.
6. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in uses of estrogen replacement therapy. Arch Intern Med 1991;151:75.
7. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular mortality in women over 50: The Framingham Study. N Engl J Med 1985;313:1038.
8. Hemminki E, Topo P, Malin M, Kangas I. Physicians' views on hormone therapy around and after menopause. Maturitas 1993;16:163.
9. Ghali WA, Freund KM, Boss RD, Ryan CA, Moskowitz MA. Menopausal hormone therapy: Physician awareness of patient attitudes. Am J Med 1997;103:3.
10. Holzman GB, Ravitch MM, Metheny W, Rothert ML, Holmes M, Hoppe RB. Physicians' judgments about estrogen replacement therapy for menopausal women. Obstet Gynecol 1984;63:303.
11. Greendale GA, Carlson KJ, Schiff I. Estrogen and progestin therapy to prevent osteoporosis: Attitudes and practices of general internists and gynecologists. J Gen Intern Med 1990;5:464.
12. Seto TB, Taira DA, Davis RB, Safran C, Phillips RS. Effect of physician gender on the prescription of estrogen replacement therapy. J Gen Intern Med 1996;11:197.
13. Lacroix A, Newton K, Phelan E. Physician gender and estrogen replacement therapy. J Gen Intern Med 1997;12:334.
14. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47.
15. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiologic studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047.
16. Nanda K, Bastian LA, Hasselblad V, Simel DL. Hormone replacement therapy and colorectal cancer risk: A meta-analysis. Abstract Presentation, Annual Meeting, American College of Obstetricians and Gynecologists, New Orleans, LA, May 1998.
17. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia. JAMA 1998;279:688.
18. Douketis JD, Ginsberg JS, Holbrook A, Crowther M, Duku EK, Burrows RF. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy. Arch Intern Med 1997;157:1522.
19. Pasley BH, Standfast SJ, Katz SH. Prescribing estrogen during menopause: Physician survey of practices in 1974 and 1981. Public Health Rep 1984;99:424.
20. Ross RK, Paganini-Hill A, Roy S. Past and present preferred prescribing practices of hormone replacement therapy among Los Angeles gynecologists: Possible implications for public health. Am J Public Health 1988;78:516.
21. Stafford RS, Saglam D, Causino N. Blumenthal D. Low rates of hormone replacement in visits to United States primary care physicians. Am J Obstet Gynecol 1997;177:381.
22. Bryce FC, Lilford RJ. General practitioners use of hormone replacement therapy in Yorkshire. Eur J Obstet Gynaecol Reprod Biol 1990;37:55.
23. Baker LC, Cantor JC. Physician satisfaction under managed care. Health Aff (Millwood) 1993;12 Suppl: 258.
24. Collins KS, Sandman DR. The impact of managed care on practicing physicians. Bull NY Acad Med 1996; 73:490.